Short-Term Gains Amid Long-Term Challenges
In the immediate term, Dhampur Bio has shown signs of recovery, with the stock appreciating by 2.94% over the past week, outperforming the Sensex which declined by 0.52% during the same period. Over the last month, the stock has further extended gains to 5.49%, surpassing the benchmark’s 1.13% rise. This short-term momentum is supported by a three-day consecutive gain, during which the stock has delivered a cumulative return of 3.3%. Such performance suggests renewed investor interest and a possible technical rebound.
Trading activity also reflects this uptick, with delivery volumes on 10 Dec rising slightly by 0.3% compared to the five-day average, indicating increased investor participation. The stock’s price currently sits ...
Read More












